| Drug-Target Information | ||||||||
|---|---|---|---|---|---|---|---|---|
| Drug Name | Target Name | Drug Type | Target Type | Source | Drug MeSHID | Interaction Score | Drug Status | Target Action |
| cl-316,243 | adrenergic receptor beta-3 | NA | Successful target | TTD , DGIDB | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Obesity[MeSHID:D009765] |
NA | phase 2 | unknown |
| cl-316,243 | mitochondrial uncoupling protein 1 | NA | Clinical trial target | TTD , DGIDB | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Obesity[MeSHID:D009765] |
NA | phase 2 | unknown |
| cl-316,243 | mitochondrial uncoupling protein 2 | NA | Clinical trial target | TTD , DGIDB | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Obesity[MeSHID:D009765] |
NA | phase 2 | unknown |
| cl-316,243 | mitochondrial uncoupling protein 3 | NA | Clinical trial target | TTD , DGIDB | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Obesity[MeSHID:D009765] |
NA | phase 2 | unknown |
| click here to return to the previous page | ||||||||